Titleist Asset Management, Ltd. Ginkgo Bioworks Holdings, Inc. Transaction History
Titleist Asset Management, Ltd.
- $426 Million
- Q4 2022
A detailed history of Titleist Asset Management, Ltd. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Titleist Asset Management, Ltd. holds 2,309,803 shares of DNA stock, worth $21.9 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
2,309,803
Previous 2,259,731
2.22%
Holding current value
$21.9 Million
Previous $7.05 Million
44.64%
% of portfolio
0.92%
Previous 1.61%
Shares
5 transactions
Others Institutions Holding DNA
# of Institutions
40Shares Held
48.1MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY42MShares$397 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA1.5MShares$14.2 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V81.15MShares$10.8 Million0.0% of portfolio
-
Benjamin F. Edwards & Company, Inc. St. Louis, MO235KShares$2.22 Million0.0% of portfolio
-
Aj Wealth Strategies, LLC197KShares$1.87 Million0.02% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $12.2B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...